Arq, Inc. ARQ
Nasdaq · XNAS · stock · Miscellaneous Chemical Products
Chart by TradingView
3/9
Piotroski F — financial health
1.51
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $120.3M | -$52.6M | — | — | $168.0M |
| 2024 | $109.0M | -$5.1M | — | — | $217.3M |
| 2023 | $99.2M | -$12.2M | — | — | $178.4M |
| 2022 | $103.0M | -$8.9M | — | — | $140.0M |
| 2021 | $100.3M | $60.4M | — | — | $147.3M |
| 2020 | $67.4M | -$20.3M | — | — | $85.2M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Voncannon Jay Loring | Chief Financial Officer | 2026-05-04 | Sell | 16,709 | $2.27 |
| Wong Joseph M | Chief Technology Officer | 2026-03-23 | Tax withheld | 10,085 | $2.27 |
| Smith Claiborne Benson | Gen Counsel, Corp Secretary | 2026-03-23 | Tax withheld | 8,025 | $2.27 |
| Hansen Stacia | Chief Accounting Officer | 2026-03-23 | Tax withheld | 8,894 | $2.27 |
| Rasmus Robert E. | Chief Executive Officer | 2026-03-23 | Tax withheld | 845 | $2.27 |
| Campbell-Breeden Richard | director | 2026-03-23 | Buy | 150,000 | $2.21 |
| Wong Joseph M | Chief Technology Officer | 2026-03-17 | Buy | 10,000 | $1.89 |
| Smith Claiborne Benson | Gen Counsel, Corp Secretary | 2026-03-16 | Buy | 1,000 | $1.92 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.51 (grey)
- Working capital / assets 0.007
- Retained earnings / assets 0.06
- EBIT / assets -0.23
- Equity / liabilities 2.682
Source: SEC EDGAR filings · CIK 0001515156 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.